• Explore /
  • Poster
  • / PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).

PROSPER: A phase III randomized study comparing perioperative nivolumab (nivo) versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN 8143).

Abstract Poster

Authors

null

Lauren Christine Harshman

Dana-Farber Cancer Institute, Boston, MA

Lauren Christine Harshman , Maneka Puligandla , Naomi B. Haas , Mohamad Allaf , Charles G. Drake , David F. McDermott , Sabina Signoretti , David Cella , Rajan T. Gupta , Brian M. Shuch , Toni K. Choueiri , Primo Lara Jr., Anil Kapoor , Daniel Yick Chin Heng , Michael A.S. Jewett , Viraj A. Master , M. Dror Michaelson , Bradley C. Leibovich , Deb Maskens , Michael Anthony Carducci

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Nonprostate) Cancer

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT03055013

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS4597)

DOI

10.1200/JCO.2019.37.15_suppl.TPS4597

Abstract #

TPS4597

Poster Bd #

417b

Abstract Disclosures

Similar Posters

First Author: Lauren Christine Harshman

First Author: Naomi B. Haas

First Author: Lauren Christine Harshman

First Author: Mohamad E. Allaf